News
A US$80m grant will support exceptional longevity research into families whose members live far longer than average, as scientists look for genetic clues to healthy ageing. The funding renews support for the Long Life Family Study, a long-running international project examining multiple generations of families with unusually high numbers of people living to 100 and [...]
Hims & Hers Health beat Q4 earnings forecasts, though shares fell 2 per cent in aftermarket trading after the telehealth firm issued full-year guidance largely in line and a softer first quarter. The company reported Q4 earnings per share of US$0.08, ahead of analyst expectations of $0.05. Revenue rose to US$617.8m, compared with consensus forecasts [...]
LTIMindtree has secured a seven-year US$100m medtech deal to develop and support hearing aids and related digital tools for a European medical technology company. The Indian IT services company said the Europe-based client, which provides hearing solutions, has not been named. Under the agreement, LTIMindtree will develop and support the client’s main hearing [...]
By Donna Smith, Director of Strategic Solutions, Insource Cancer care is one of Scotland’s most urgent health system challenges and alarmingly 1 in 2 patients will have a cancer diagnosis in their lifetime. Thousands of people each year experience the fear and uncertainty whilst waiting for a cancer diagnosis. For me, the importance of timely [...]
Guardant Health has acquired Israeli diagnostics startup MetaSight in a deal valued at up to US$150m, highlighting growing international investment in Israel’s health technology sector. The agreement includes US$60m in upfront cash, before standard deductions, along with up to US$90m in contingent payments tied to future performance milestones. The acquisition is expected to accelerate the [...]
Hims & Hers has agreed to buy Eucalyptus in a deal worth up to US$1.15bn, expanding its international digital health reach beyond the US. Eucalyptus, founded in 2019, operates consumer health brands including Juniper and Pilot across Australia, the UK, Germany, Japan and Canada. The company says it has served more than 775,000 customers and [...]
Sanofi has backed Altesa BioSciences in a US$75m series B round for the rhinovirus-focused biotech led by former acting FDA commissioner Brett Giroir. The funding will mainly support a phase 2b study, a mid-stage clinical trial, of vapendavir, an oral antiviral pill for patients with chronic obstructive pulmonary disease (COPD), a long-term lung condition that [...]
A new £4.2m research institute in North East England will use routine eye scans to improve eye health and spot early signs of serious illness. The Northern Ophthalmic Research and Innovation Institute (NORI) brings together university experts, the NHS, local authorities and industry to use routine eye scans to spot early signs of serious illness. [...]
Sleep trackers may spot depression relapse weeks before symptoms return, a study of 93 adults with remitted major depressive disorder suggests. Researchers followed people whose symptoms had eased but who remained at risk of recurrence. Participants wore research-grade wrist actigraphy devices, which track movement to estimate sleep and activity, for up to two years, generating [...]
GE HealthCare has secured a US$35m BARDA contract expansion for AI ultrasound tools intended to help non-expert users assess trauma patients. The deal with the US Biomedical Advanced Research and Development Authority (BARDA) builds on a US$44m agreement struck in 2023 to fund tools for diagnosing patients in mass casualty incidents. Under the original deal, [...]

















